Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Comment by rrrrrrrrrrrron Jan 27, 2020 3:05pm
93 Views
Post# 30604839

RE:RE:RE:RE:RE:“In Our Favor” ???

RE:RE:RE:RE:RE:“In Our Favor” ???Daniel, you keep talking about $25M.  Can you break that down?
 
In terms of the original D2 funding PSF is only short $5.94M (Nov default payment by EMH).  If PSF requires more funds they have a provision in the shareholder agreement to call for them.  It is clear VFF has the $5.94M should it be needed.  EMH is stating they are prepared to set off the Nov payment with the $13M loan.  Hard to see an issue with D2 funding?

<< Previous
Bullboard Posts
Next >>